|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Current Assets | ||||||||||||
| Cash | ||||||||||||
| Deferred offering costs | ||||||||||||
| Prepaid expenses and other assets | ||||||||||||
| Prepaid franchise and income taxes | ||||||||||||
| Other current asset | ||||||||||||
| Total Current Assets | ||||||||||||
| Investments held in Trust Account | ||||||||||||
| Cash and investments held in Trust Account | ||||||||||||
| Total Assets | ||||||||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||||||
| Current Liabilities | ||||||||||||
| Accrued offering costs and expenses | ||||||||||||
| Related party payable - administrative fee | ||||||||||||
| Promissory note – related party | ||||||||||||
| Due to related party - administrative fee | ||||||||||||
| Due to related party | ||||||||||||
| Due to SKG | ||||||||||||
| Other Liability | ||||||||||||
| Related Party | ||||||||||||
| Total other Liability | ||||||||||||
| Accounts payable and accrued expenses | ||||||||||||
| Franchise tax payable | ||||||||||||
| Income tax payable | ||||||||||||
| Excise tax payable | ||||||||||||
| Promissory note | ||||||||||||
| Related Party | ||||||||||||
| Nonrelated Party | ||||||||||||
| Total promissory note | ||||||||||||
| Total Current Liabilities | ||||||||||||
| Deferred underwriting fee payable | ||||||||||||
| Total Liabilities | ||||||||||||
| Common stock subject to possible redemption, $0.0001 par value; 20,000,000 shares authorized; 6,900,000 shares issued and outstanding at redemption value of $10.50 and $10.19 as of September 30, 2024 and December 31, 2023, respectively | ||||||||||||
| Common stock subject to possible redemption, $0.0001 par value; 20,000,000 shares authorized; 1,700,703 shares issued and outstanding at redemption value of $11.70 and $11.34 as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||
| Stockholders’ Deficit | ||||||||||||
| Common stock, $0.0001 par value; 20,000,000 shares authorized; 2,047,045 shares issued and outstanding (excluding 1,700,703 shares subject to possible redemption as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated deficit | ||||||||||||
| Total Stockholders’ Deficit | ||||||||||||
| Total Stockholders’ Deficit | ||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT |
Loading...
